Showing 1381-1390 of 2166 results for "".
The Four Stages of Diabetic Retinopathy
https://modernod.com/topics/retina/the-four-stages-of-diabeticretinopathy/37941/What you need to know to optimize patient care.Allergy Management in Scleral Lens Wearers
https://modernod.com/topics/contact-lenses/allergy-management-in-scleral-lens-wearers/37910/Having a good baseline assessment and thorough history helps to ensure success.Basic Allergy Diagnosis and Treatment
https://modernod.com/mod-issues/2019-mar/basic-allergy-diagnosis-and-treatment/37893/Is it allergy or is it dry eye disease? The answer matters, and in-office testing can prove enlightening.First Robotic Cataract Surgery Performed
https://modernod.com/podcasts/eyewire-news-the-podcast/first-robotic-cataract-surgery-performed/39875/Uday Devgan, MD, shares his experience performing the world’s first robotic cataract surgery; Konan Medical receives CE Mark for its objectiveFIELD Analyzer perimetry device; and Biotech Healthcare launches a new full visual range EDOF IOL. Learn more about your ad choices. Visit megaphone.fm/adchoCorneal Therapies Come and Go
https://beta.modernod.com/articles/significant-findings/corneal-therapies-come-and-go/39851/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatLenz Therapeutics' Vizz Commerically Launched
https://modernod.com/podcasts/eyewire-news-the-podcast/lenz-therapeutics-vizz-commerically-launched/39874/A first-of-its-kind presbyopia eye drop is now commercially available; Lumibird introduces ICL Guru Integration on its ultrasound platform; and the makers of gene therapy candidates for retinal diseases provide clinical updates. Learn more about your ad choices. Visit megaphone.fm/adchoicesThe AlloFlo™ Uveo
https://modernod.com/articles/visionary-breakthroughs/the-alloflosupsup-uveo/39824/Unlocking the uveoscleral pathway post-MIGS.The SpyGlass Pharma™ Drug Delivery Platform
https://modernod.com/articles/visionary-breakthroughs/the-spyglass-pharma-drug-delivery-platform-1/39826/Drug delivery integrated into the cataract surgery workflow.BRIMOCHOL™ PF for Presbyopia
https://modernod.com/articles/visionary-breakthroughs/brimocholsupsup-pf-for-presbyopia/39827/A synergistic, next-generation therapeutic for presbyopia.Watch for Complications of Systemic Meds
https://beta.modernod.com/articles/significant-findings/watch-for-complications-of-systemic-meds/39848/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat